Internal Medicine, Infectious Disease · Houston, TX
NPI
1245239177
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
9055 Katy Fwy, Suite 400
Houston, TX, 77024
Phone (713) 467-1365
Medicare paid, 2024
$138K
1,887 services
Medicare patients, 2024
217
Average age 77
Drug cost, 2024
$1.8M
1,999 prescriptions
Company payments, 2024
$50.41
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan J Chapman Jr. was code 99232 (hospital e&m - subsequent), 1,472 times for 189 patients. In total Alan J Chapman Jr. billed 1,887 services in 6 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,472 | 189 | $62.91 | $93K |
| 99233 Hospital E&M - Subsequent | Facility | 193 | 75 | $94.48 | $18K |
| 99223 Hospital E&M - Initial | Facility | 167 | 164 | $138.05 | $23K |
| 99231 Hospital E&M - Subsequent | Facility | 38 | 12 | $39.72 | $1,509 |
| 99205 Office E&M - New | Office | 12 | 12 | $156.80 | $1,882 |
By year: 2022 $144K for 2,067 services; 2023 $132K for 1,782 services; 2024 $138K for 1,887 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alan J Chapman Jr. prescribed most often to Medicare patients was Daptomycin, with 429 prescriptions and refills. In total Alan J Chapman Jr. wrote 1,999 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 429 | 429 | 67 | $797K |
| Ertapenem Ertapenem Sodium | 378 | 378 | 69 | $189K |
| Cefdinir Generic | 175 | 178 | 141 | $5,869 |
| Doxycycline Hyclate Generic | 100 | 100 | 70 | $1,802 |
| Meropenem Generic | 97 | 97 | 20 | $22K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 90 | 96 | 66 | $1,117 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 85 | 85 | 11 | $350K |
| Cefepime Hcl Generic | 70 | 70 | 14 | $16K |
| Ceftriaxone Ceftriaxone Sodium | 55 | 55 | 13 | $3,434 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 54 | 54 | 41 | $1,067 |
| Ciprofloxacin Hcl Generic | 42 | 42 | 31 | $789 |
| Micafungin Micafungin Sodium | 37 | 37 | Under 11 | $8,699 |
| Fluconazole Generic | 31 | 31 | 23 | $855 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 25 | 25 | Under 11 | $97K |
| Levofloxacin Generic | 25 | 26 | 25 | $103 |
Brand drugs: 230 claims; generic drugs: 1,769 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Alan J Chapman Jr. $50.41 ($50.41 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $25.33.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.